Wegovy diet advice on TikTok: what the evidence actually supports

What's this video probably claiming?

Sierra Robichaud lost 50 pounds on Wegovy and is sharing what she ate during that process, framed as advice for people currently on semaglutide or thinking about starting it. Based on the caption structure and the GLP-1 content space broadly, this video almost certainly includes personal food choices she attributes to her success, implicit or explicit recommendations around protein intake, portion behavior, and possibly warnings about certain foods that worsen GI side effects. Creators in this category frequently blur the line between personal anecdote and dietary prescription. Losing 50 pounds is a real, meaningful result, and semaglutide can absolutely produce that. The question is whether the dietary framework she describes reflects what clinical evidence supports, or whether it's a retrofitted narrative that gives her eating habits more causal credit than they deserve.

What does the science actually show?

The STEP 1 trial (Wilding et al., 2021, NEJM) showed that 2.4 mg semaglutide weekly produced an average 14.9% body weight reduction over 68 weeks in adults with obesity. A meaningful portion of that effect is pharmacological. Semaglutide slows gastric emptying, reduces appetite signaling in the hypothalamus, and blunts the hedonic pull of food. Diet matters, but not in the granular way social media implies. Protein adequacy does have clinical backing in this context. A 2023 review in Obesity Reviews (Koliaki et al.) noted that higher protein intakes help preserve lean mass during rapid GLP-1-driven weight loss, which is a real concern. The SCALE trial data on liraglutide showed similar lean mass trade-offs. So the protein angle is not invented. But the idea that any particular food list or meal structure is why someone lost 50 pounds on Wegovy rather than the drug itself is not supported by the trial literature.

Where does the social media noise diverge from clinical reality?

The biggest problem in this content category is attribution error. Creators lose weight, catalog what they ate, and present the diet as the mechanism. But the STEP trials did not require specific dietary protocols beyond modest caloric guidance. Participants across a range of eating patterns lost substantial weight. When TikTok creators say things like "you need to eat this way on Wegovy," they are generalizing from an n of 1 in a context where the drug is doing most of the heavy lifting. There is also a recurring and misleading narrative in GLP-1 content around "foods that work with the medication." Fatty, greasy foods can worsen nausea on semaglutide, and that is real, but framing avoidance of those foods as a dietary strategy rather than side effect management misrepresents the pharmacology. Creators rarely mention that appetite suppression itself changes food preference, making their current food choices partly an effect, not a cause, of treatment.

What should you actually know?

If you are on semaglutide or considering it, here is what the clinical picture actually supports. Adequate protein intake, roughly 1.2 to 1.6 grams per kilogram of body weight daily, is worth prioritizing because GLP-1-driven weight loss can accelerate muscle loss, particularly in older adults. Resistance training compounds that benefit. Avoiding high-fat, high-sugar foods during dose escalation reduces GI side effects, per prescribing guidance, but is not a permanent dietary rule. Caloric deficit still applies. The drug reduces appetite, which makes deficit easier to sustain, but it does not override thermodynamics. Personal testimonials like this video can be motivating and contain genuinely useful experiential tips. But they should not replace a conversation with a registered dietitian or a prescribing clinician who can account for your specific metabolic profile, not Sierra's.